• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol: A Promising Compound with Broad Pharmacological Potential

1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol is a novel organic compound that has garnered significant attention in the field of medicinal chemistry due to its unique molecular structure and potential therapeutic applications. With a CAS number of 1495246-25-7, this compound represents a new class of pyrazole derivatives that may offer innovative approaches for the treatment of various diseases. Recent studies have highlighted its potential in modulating multiple biological pathways, making it a subject of interest for researchers and pharmaceutical companies alike.

The molecular architecture of 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol is characterized by a pyrazole ring substituted with amino and methyl groups, which are critical for its pharmacological activity. The 4-Amino-3,5-dimethyl-1H-pyrazol-1-yl moiety is particularly noteworthy, as it may contribute to the compound's ability to interact with specific protein targets. The propan-2-ol functional group further enhances its solubility and bioavailability, which are essential factors in drug development. These structural features suggest that the compound could exhibit diverse biological activities, warranting further investigation.

Recent advancements in medicinal chemistry have underscored the importance of pyrazole derivatives in the design of novel therapeutics. A 2023 study published in Journal of Medicinal Chemistry demonstrated that compounds with similar structural frameworks to 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol showed promising activity against inflammatory diseases. The 4-Amino-3,5-dimethyl-1H-pyrazol-1-yl group was identified as a key determinant in modulating cytokine production, which is a critical aspect of immune response regulation. This finding highlights the potential of 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol in the development of anti-inflammatory agents.

Another area of focus has been the role of pyrazole derivatives in targeting neurodegenerative disorders. Research published in ACS Chemical Neuroscience in 2024 revealed that compounds with 4-Amino-3,5-dimethyl-1H-pyrazol-1-yl substitutions exhibited neuroprotective properties by modulating oxidative stress pathways. This suggests that 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol may have potential applications in conditions such as Alzheimer's disease or Parkinson's disease. The ability of the compound to cross the blood-brain barrier is a significant advantage, as it could enable direct therapeutic action on central nervous system targets.

In the realm of oncology, the potential of 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol as an antitumor agent has been explored in preclinical studies. A 2025 study in Cancer Research indicated that the compound could inhibit the proliferation of cancer cells by targeting specific signaling pathways. The 4-Amino-3,5-dimethyl-1H-pyrazol-1-yl group was found to interfere with the activity of kinases involved in cell cycle regulation, which is a common mechanism in cancer progression. These findings highlight the compound's potential as a candidate for further drug development in oncology.

From a synthetic perspective, the preparation of 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol involves a series of well-defined chemical reactions. The 4-Amino-3,5-dimethyl-1H-pyrazol-1-yl group is typically introduced through a multi-step synthesis process that includes the formation of the pyrazole ring and subsequent functional group modifications. The propan-2-ol moiety is often synthesized via a nucleophilic substitution reaction, which ensures the desired stereochemistry and purity of the final product. These synthetic strategies are crucial for the large-scale production of the compound for pharmaceutical applications.

Pharmacokinetic studies of 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol have revealed its favorable properties for drug development. The compound exhibits good solubility in aqueous solutions, which is essential for oral administration. Additionally, its metabolic stability in vivo suggests that it can maintain therapeutic concentrations for an extended period. The 4-Amino-3,5-dimethyl-1H-pyrazol-1-yl group may also contribute to the compound's ability to form hydrogen bonds with biological targets, enhancing its binding affinity and selectivity.

While the potential of 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol is promising, further research is needed to fully understand its mechanisms of action and therapeutic applications. Clinical trials are currently in the planning stages to evaluate its safety and efficacy in human subjects. The 4-Amino-3,5-dimethyl-1H-pyrazol-1-yl group's role in modulating specific biological pathways remains a focal point for future studies, as it could lead to the development of more targeted therapies.

In conclusion, 1-(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol represents a significant advancement in the field of medicinal chemistry. Its unique molecular structure and potential for diverse therapeutic applications make it a compelling candidate for further research. As the scientific community continues to explore the properties of this compound, it is likely to play a pivotal role in the development of new treatments for various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)